|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
157,644,000 |
Market
Cap: |
N/A |
Last
Volume: |
3,641,286 |
Avg
Vol: |
1,652,431 |
52
Week Range: |
$0.034 - $0.034 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Urdal David |
SVP, Chief Scientific Officer |
|
2011-01-21 |
4 |
D |
$35.05 |
$37,679 |
D/D |
(1,075) |
687,420 |
|
- |
|
Hamm Richard F Jr |
SVP, General Counsel Secretary |
|
2011-01-21 |
4 |
D |
$35.05 |
$43,427 |
D/D |
(1,239) |
222,943 |
|
- |
|
Cox Greg |
VP, Finance |
|
2011-01-21 |
4 |
D |
$35.05 |
$19,172 |
D/D |
(547) |
34,754 |
|
- |
|
Monteith William |
EVP Technical Operations |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,500 |
21,112 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-01-20 |
4 |
D |
$13.37 |
$68,347 |
D/D |
(5,112) |
671,057 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
56,101 |
294,926 |
|
- |
|
Granadillo Pedro P |
Board of Director |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
12,251 |
|
- |
|
Frohlich Mark W |
See Remarks |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
21,038 |
204,754 |
|
- |
|
Brewer Richard B |
Director |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
20,157 |
|
- |
|
Bishop Hans Edgar |
Chief Operating Officer |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
28,051 |
165,051 |
|
- |
|
Schiffman Greogry T |
CFO, SVP of Finance & Treasure |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
21,038 |
221,230 |
|
- |
|
Urdal David |
SVP, Chief Scientific Officer |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
14,026 |
688,495 |
|
- |
|
Hamm Richard F Jr |
SVP, General Counsel Secretary |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
17,532 |
224,182 |
|
- |
|
Ranieri Richard J |
SVP, Human Resources |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
21,038 |
66,038 |
|
- |
|
Cox Greg |
VP, Finance |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,500 |
35,301 |
|
- |
|
Watson Douglas G |
Director |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
29,757 |
|
- |
|
Stump David C |
Director |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
7,047 |
|
- |
|
Dziurzynskio Bogdan |
Director |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
28,507 |
|
- |
|
Canet Geraldo |
Director |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
19,757 |
|
- |
|
Bayh Susan B |
Board of Director |
|
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
20,757 |
|
- |
|
Urdal David |
SVP, Chief Scientific Officer |
|
2011-01-18 |
4 |
D |
$36.90 |
$6,863 |
D/D |
(186) |
674,469 |
|
- |
|
Gold Mitchell |
President & Chief Executive Of |
|
2011-01-18 |
4 |
D |
$36.90 |
$31,550 |
D/D |
(855) |
238,825 |
|
- |
|
Cox Greg |
VP, Finance |
|
2011-01-18 |
4 |
D |
$36.90 |
$1,771 |
D/D |
(48) |
25,801 |
|
- |
|
Hamm Richard F Jr |
SVP, General Counsel Secretary |
|
2011-01-18 |
4 |
D |
$36.90 |
$6,863 |
D/D |
(186) |
206,650 |
|
- |
|
Frohlich Mark W |
See Remarks |
|
2011-01-18 |
4 |
AS |
$36.78 |
$105,018 |
D/D |
(2,855) |
183,716 |
|
- |
|
721 Records found
|
|
Page 16 of 29 |
|
|